🩺 Lilly-Backed TRex Bio Closes Flat at $14 After $117M IPO
Eli Lilly-backed TRex Bio closed its first trading day flat at its $14 IPO price, raising $117M. Shares opened at $13.50, dipped below $14, spiked to $15.50 late, then settled.

🩺 Lilly-Backed TRex Bio Closes Flat at $14 After $117M IPO
Eli Lilly-backed TRex Bio closed its first trading day flat at its $14 IPO price, raising $117M. Shares opened at $13.50, dipped below $14, spiked to $15.50 late, then settled.
💊 Eli Lilly GLP-1 Franchise Hits $15.7B Revenue, Growing 76% as Stock Slips
Mounjaro and Zepbound now generate $15.7B in combined revenue, up 76%, keeping Eli Lilly's weight-loss franchise the sector's dominant money machine.
New Insights from Eli Lilly's Clinical Trials on Psoriasis Treatment Revealed #USA #Indianapolis #Zepbound #Lilly #Taltz
💊 Eli Lilly Jumps 2.20% to $1,182.91 as GLP-1 Franchise Drives Premium Valuation
Eli Lilly shares climbed 2.20% to $1,182.91, sitting in the 87th percentile of their 52-week range as investors keep paying up for the company's obesity and diabetes portfolio.
Autumn walk
#Lilly #Halloween #originalcharacters #oc #drawing #art #sketch
🧠Meet Dr Kálmán Benedikt Bódis, #EFSD & #Lilly Young Investigator Research Award recipient. His project explores how restoring blood flow affects wound microbiome in #diabeticfoot ulcers for more personalised treatment.
📖 link.springer.com/article/10.1...
Supported by Lilly Diabetes International.
Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s
replaye.com/why-lilly-an...
#News #Lilly #Novo #EliLilly #Amylin #ObesityDrugs #Drugs #GLP1 #Health
Pharmalot.. Pharmalittle.. Good Morning: We’re reading about Trump's plan to lower Medicare drug prices, a Lilly obesity drug, and more news.. statnews.com/pharmalot/20... #pharma #Trump #Medicare #obesity #weight #layoffs #FDA #animals #Lilly #Novo #AstraZeneca #Sanofi #Regeneron
🥇 Lilly Slides 2% As EASD Deck Lands With No New Guidance
Eli Lilly presented at the 2026 EASD annual meeting, publishing a slide deck tied to the event.
Shares fell 2.02% to 1,160.75, holding the 82nd percentile of the 52-week range after a 7.44% YTD run.
Besutiful #Lilly needs a loving furrever family today! 💔
Please at least SHARE!! 🙏🐾
Lilly Unveils Ambitious Commitment to Close Diabetes Treatment Gaps in Low-Income Countries #United_States #Indianapolis #Lilly #diabetes #Foundayo
Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and Centene in focus
Pharmalot.. Pharmalittle.. Good Morning: We’re reading about a reticent FDA commish nominee, a Novo deal, and more news.. statnews.com/pharmalot/20... #pharma #FDA #Overton #Lilly #Novo #AstraZeneca #patents #Indonesia
FDA Approves Lilly's Onswik: A New Once-Weekly Insulin for Type 2 Diabetes Management #United_States #Indianapolis #Lilly #diabetes #Onswik